MedPath

Comparison Between Bupivacaine-Dexmedetomidine Versus Bupivacaine-Dexamethasone in Pericapsular Nerve Group (PENG) Block

Phase 1
Recruiting
Conditions
Hip Fractures
Post Operative Pain
Interventions
Drug: Pericapsular Nerve Group (PENG) Block
Registration Number
NCT06294665
Lead Sponsor
Ain Shams University
Brief Summary

The aim of this work is to compare the effectiveness of bupivacaine- dexmedetomidine mixture versus bupivacaine-dexamethasone mixture in PENG Block as Post-operative Analgesia in Hip surgeries

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
60
Inclusion Criteria
  1. Age 18-65 years.
  2. Sex: Both sexes.
  3. American Society of Anaesthesiologists (ASA) Physical Status Class I and II.
  4. Scheduled for hip surgeries under spinal anaesthesia.
Exclusion Criteria
  1. Declining to give written informed consent.
  2. History of allergy to the medications used in the study.
  3. Contraindications to regional anesthesia (including patient refusal, coagulopathy and local infection).
  4. Psychiatric disorder.
  5. American Society of Anesthesiologists (ASA) Physical Status Class III and IV.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Group A : ( Bupivacaine + Dexmedetomidine )Pericapsular Nerve Group (PENG) BlockGroup A : will receive bupivacaine 0.25% + dexmedetomidine 1 mic/kg, total volume (20 ml)
Group B: ( Bupivacaine + Dexamethasone )Pericapsular Nerve Group (PENG) BlockGroup B : will receive bupivacaine 0.25% +dexamethasone (8 mg), total volume(20 ml).
Primary Outcome Measures
NameTimeMethod
The time to the first request of analgesia9 months

The time interval between the onset of the local infiltration done at the end of the operation and the first request to postoperative analgesia.

Secondary Outcome Measures
NameTimeMethod
Total doses of analgesia (Nalbuphine) given to patients in 24 hours postoperatively9 months
Occurrence of side effects of drugs.9 months

Trial Locations

Locations (1)

Ain Shams University

🇪🇬

Cairo, Egypt

Ain Shams University
🇪🇬Cairo, Egypt
Fatma Ebeid
Contact
+201095569596
dr.fatma_ebeid@yahoo.com
Mohamed Salama
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.